Australia has opened the doors to a vaccine skin patch manufacturing facility in hopes to reduce the complexities and costs associated with existing vaccines and be better position the country for future pandemics.
Situated in Brisbane’s riverside suburb of Hamilton, biotechnology company Vaxxas expects to manufacture and distribute the first commercially available vaccine patches within three to five years.
